v3.26.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating Expenses        
Research and development $ 150,769 $ 324,068 $ 269,179 $ 563,672
General and administrative expenses 344,997 391,494 723,781 705,123
Share-based compensation   15,977 39,170
Total Operating Expenses 495,766 731,539 992,960 1,307,965
Loss from operations (495,766) (731,539) (992,960) (1,307,965)
Financial Expenses, net (10,967) (15,107) (8,714) (14,804)
Amortization of debt discount (75,362) (14,595) (236,787) (14,595)
Change in fair value of derivative liability (43,048) 1,903 (25,348) 1,903
Total other expense (129,377) (27,799) (270,849) (27,496)
Loss before provision for income taxes (625,143) (759,338) (1,263,809) (1,335,461)
Provision for income taxes
Net loss $ (625,143) $ (759,338) $ (1,263,809) $ (1,335,461)
Net loss per common share        
Net loss per Common Stock, Basic (in Dollars per share) $ (0) $ (0) $ (0) $ (0)
Net loss per Common Stock, Diluted (in Dollars per share) $ (0) $ (0) $ (0) $ (0)
Weighted-average common shares outstanding        
Weighted-average Common Stock outstanding, Basic (in Shares) 976,997,116 956,997,116 976,552,672 956,997,116
Weighted-average Common Stock outstanding, Diluted (in Shares) 976,997,116 956,997,116 976,552,672 956,997,116